GlassScriptPhysician profile
Brian R Kelly
NPI 1043406291
$269.64
in general payments reported to CMS, 2019-2025
11 companies · $40.42 in 2025
The $40.42 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.56 · 2021: $33.97 · 2022: $76.62 · 2023: $75.78 · 2024: $29.29 · 2025: $40.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $60.20 | 2022-2025 | Exparel, Zilretta, Iovera |
| Picard Medical INC. | $37.52 | 2023 | |
| Mindray Ds USA, INC. | $29.29 | 2024 | A7 Anesthesia System |
| Cvrx, INC. | $25.50 | 2022 | |
| Atricure, INC. | $24.46 | 2023 | |
| Merck Sharp & Dohme LLC | $17.93 | 2021 | |
| Fisher & Paykel Healthcare INC | $16.98 | 2025 | Fisher & Paykel Healthcare |
| B. Braun Medical INC. | $16.04 | 2021 | |
| Conmed Corporation | $14.36 | 2022 | |
| Heron Therapeutics, INC. | $13.80 | 2023 | Aponvie |
| Mallinckrodt Enterprises LLC | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.